Development of new drugs to treat diseases other than the novel coronavirus looks set to be delayed as the outbreak…...
Please subscribe to read the full story.
Bristol-Myers Squibb
Nitto Denko Targets Life Science as Third Business Pillar
Nitto Denko Corp. (TYO:6988) is looking to rear its life science operations into a third key pillar of business. Fiscal…...
Please subscribe to read the full story.
PeptiDream to Set up CMO for Specialized Peptides
PeptiDream Inc. (TYO:4587) is establishing Japan’s first contract manufacturing organization (CMO) for specialized peptides, which are attracting interest as post-peptide…...
Please subscribe to read the full story.
